Trial · NCT00292370
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase I - Open-Label Paroxetine (OLP) | STARTED | Arm 1/Open-Label (OL) Paroxetine | 124 | |
| Phase I - Open-Label Paroxetine (OLP) | STARTED | Arm 2/OL Paroxetine & Double-blind Placebo | 0 | |
| Phase I - Open-Label Paroxetine (OLP) | STARTED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 0 | |
| Phase I - Open-Label Paroxetine (OLP) | COMPLETED | Arm 1/Open-Label (OL) Paroxetine | 78 | |
| Phase I - Open-Label Paroxetine (OLP) | COMPLETED | Arm 2/OL Paroxetine & Double-blind Placebo | 0 | |
| Phase I - Open-Label Paroxetine (OLP) | COMPLETED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 0 | |
| Phase I - Open-Label Paroxetine (OLP) | NOT COMPLETED | Arm 1/Open-Label (OL) Paroxetine | 46 | |
| Phase I - Open-Label Paroxetine (OLP) | NOT COMPLETED | Arm 2/OL Paroxetine & Double-blind Placebo | 0 | |
| Phase I - Open-Label Paroxetine (OLP) | NOT COMPLETED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 0 | |
| Phase II: OLP + DB Quetiapine or Placebo | STARTED | Arm 1/Open-Label (OL) Paroxetine | 0 | |
| Phase II: OLP + DB Quetiapine or Placebo | STARTED | Arm 2/OL Paroxetine & Double-blind Placebo | 25 | |
| Phase II: OLP + DB Quetiapine or Placebo | STARTED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 25 | |
| Phase II: OLP + DB Quetiapine or Placebo | COMPLETED | Arm 1/Open-Label (OL) Paroxetine | 0 | |
| Phase II: OLP + DB Quetiapine or Placebo | COMPLETED | Arm 2/OL Paroxetine & Double-blind Placebo | 21 | |
| Phase II: OLP + DB Quetiapine or Placebo | COMPLETED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 18 | |
| Phase II: OLP + DB Quetiapine or Placebo | NOT COMPLETED | Arm 1/Open-Label (OL) Paroxetine | 0 | |
| Phase II: OLP + DB Quetiapine or Placebo | NOT COMPLETED | Arm 2/OL Paroxetine & Double-blind Placebo | 4 | |
| Phase II: OLP + DB Quetiapine or Placebo | NOT COMPLETED | Arm 3/OL Paroxetine & Double-blind Quetiapine | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00292370/flow